Last reviewed · How we verify
NCT05735899
Evaluation of the Safety and Efficacy of Meniscal Preservation Surgery
trial in Meniscal Extrusion in 20 participants. Status unknown.
16 August 2025
Quick facts
| Lead sponsor | Andrews Research & Education Foundation |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 16 August 2022 |
| Primary completion | 16 August 2025 |
| Estimated completion | 16 August 2025 |
| Sites | 1 location across United States |
Conditions studied
- Meniscal Extrusion — all drugs for Meniscal Extrusion →
Sponsor
Andrews Research & Education Foundation
Who can join
18 and older, any sex, with Meniscal Extrusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to demonstrate the safety and efficacy of surgical meniscal preservation techniques to correct meniscal extrusion. The primary endpoint for safety will be analysis of the total number and types of adverse events (AEs) and serious adverse events (SAEs). The primary endpoint for efficacy will include analysis of patient report outcome measures (PROMs). H0 - Participants undergoing surgical meniscal preservation to correct meniscal extrusion will not exhibit a limited number of safety events nor have favorable outcomes. H1- Participants undergoing surgical meniscal preservation to correct meniscal extrusion will exhibit a limited number of safety events and have favorable outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05735899
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Meniscal Extrusion
Currently open trials in the same condition.
- NCT06906783 — Transtibial Pull Out Method Versus Suture Anchor Method for Meniscus Extrusion · NA · recruiting
Other Andrews Research & Education Foundation trials
Trials by the same sponsor.
- NCT05573347 — Cellular Content of Bone Marrow Aspiration, Comparison · unknown
- NCT05573412 — Comparison of Proliferative Potential of H-PBSC Based on Demographics and Cryopreservation Time · unknown
- NCT07213726 — Quantification of Progenitor Cell Circulation Following Vascular Resistance Exercise Using Delfi Tourniquet System · NA · active not recruiting
- NCT05582226 — Augmentation of Anterior Cruciate Ligament Reconstruction Using Mesenchymal Stem Cells and Collagen Matrix Carrier · NA · unknown
- NCT05573386 — Comparison of Quality and Quantity of M-PRP Cellular Content Filgrastim vs. Pegfilgrastim · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05735899 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Andrews Research & Education Foundation
- Last refreshed: 21 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05735899.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing